Conception

About

Conception develops stem cell technology to create functional egg cells in the laboratory for reproductive purposes. The company uses induced pluripotent stem cells derived from blood, guiding them through developmental stages via stem cell biology, tissue engineering, and computation. Conception is developing in-vitro gametogenesis as a medical therapy with integrated ethical safeguards and a regulatory-aligned approach.

Product

Value proposition

Developing stem cell-derived reproductive cells and IVG tech to expand reproductive possibilities and enable safer, reliable in-vitro gametogenesis

Regulatory

Exploration of IVG as a medical therapy within existing regulatory frameworks; future clinical use would require formal approval

Founders

• Lauren Berson Sugarman — Founder and CEO

Products

Key features

Technologies

Investors

News

• Founders Everywhere: Lauren Berson Sugarman · 2025-02-12T13:46:08.000Z
• Conceivable Life Sciences Secures $50 Million Series A · 2025-09-15T09:00:00.000Z
• Episode 13: Digital Fertility Revolution - AI, Community & Fertility Support | Conceive’s Lauren Berson - The Turek Clinic · 2026-03-23T18:27:27.000Z
• IVF Automation: The Most Human Story About Robots and AI — Conceivable Life Sciences · 2026-02-04T14:56:57.000Z
• Medium · 2026-02-24T14:06:01.000Z
• After A 6-Figure Fertility Journey, This Founder Built An IVF Startup With ‘Outcome Protection’ · 2026-05-20T12:00:29.000Z

Browse related software

• Clinic software in CA
• Clinic software in Berkeley
• All clinic software companies A–Z